RxDoctor Payments Data

Mystie Swingle, NP

Family · Chattanooga, TNNPI 1275942401

Payments from drug & device makers

$746in general payments, 2019–2025

Across 44 payments — averaging $16.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$157
  • AstraZeneca$93
  • Pfizer$83
  • Johnson & Johnson$49
  • Lilly USA, LLC$40
  • Arbor Pharmaceuticals, Inc.$34
  • plus $289 from 13 others

What the payments were for

  • Food & beverage$746100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$746 in reported general payments places this provider in the 55th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$1,290
Medicare patients
15
Services billed
25

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide20$21,933
FarxigaDapagliflozin Propanediol15$17,536
XareltoRivaroxaban13$13,270
Atorvastatin Calcium107$880
Albuterol Sulfate HfaAlbuterol Sulfate28$830
Valsartan14$686
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$668
Potassium Chloride25$620
Fluticasone Propionate33$603
Amlodipine Besylate122$502
Pantoprazole Sodium19$352
Gabapentin24$330
Omeprazole21$328
Pravastatin Sodium15$318
Tizanidine Hcl11$314

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$157$21,93320 claims
AstraZenecaFarxiga$93$17,53615 claims
Johnson & JohnsonXarelto$49$13,27013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 6,706 family providers in Tennessee.

Other family in Chattanooga

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →